Jpmorgan Chase & CO Epizyme, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.42 - $1.48 $101,601 - $358,025
-241,909 Reduced 97.97%
5,001 $7,000
Q1 2022

May 11, 2022
BUY
$1.06 - $2.68 $42,550 - $107,580
40,142 Added 19.41%
246,910 $284,000
Q4 2021

Feb 10, 2022
SELL
$2.5 - $5.19 $161,632 - $335,549
-64,653 Reduced 23.82%
206,768 $517,000
Q3 2021

Nov 12, 2021
BUY
$4.82 - $8.46 $1.31 Million - $2.3 Million
271,421 New
271,421 $1.39 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email